Xinxing Li
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
EIF4A3-Induced Circ_0059914 Promoted Angiogenesis and EMT of Glioma via the miR-1249/VEGFA Pathway.
Journal: Molecular neurobiology
Published: December 10, 2023
DANCR promotes glioma cell autophagy and proliferation via the miR‑33b/DLX6/ATG7 axis.
Journal: Oncology reports
Published: August 13, 2022
Extradural glomus tumor of the thoracic spine: case report and review of the literature.
Journal: Annals of palliative medicine
Published: June 04, 2021
Ventriculosinus shunt as a reliable option in the treatment of failed ventriculoperitoneal shunt: report of 19 cases and review of the literature.
Journal: Annals of palliative medicine
Published: April 22, 2021
GLIDR promotes the progression of glioma by regulating the miR-4677-3p/MAGI2 axis.
Journal: Experimental cell research
Published: April 19, 2021
Mechanical thrombectomy for middle cerebral artery occlusion associated with ovarian hyperstimulation syndrome: case report and review of the literature.
Journal: Annals of palliative medicine
Published: January 09, 2021
Clinical Uses of Diffusion Tensor Imaging Fiber Tracking Merged Neuronavigation with Lesions Adjacent to Corticospinal Tract : A Retrospective Cohort Study.
Journal: Journal of Korean Neurosurgical Society
Published: February 12, 2019
Circular RNA circ_0001946 acts as a competing endogenous RNA to inhibit glioblastoma progression by modulating miR-671-5p and CDR1.
Journal: Journal of cellular physiology
Published: September 14, 2018
Twist1 promotes astrocytoma development by stimulating vasculogenic mimicry.
Journal: Oncology letters
Published: May 19, 2018
RUNX3 is down-regulated in glioma by Myc-regulated miR-4295.
Journal: Journal of cellular and molecular medicine
Published: June 16, 2015
Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
Journal: Molecular neurobiology
Published: October 20, 2014
Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Journal: Oncology reports
Published: September 19, 2014
Last Updated: 09/26/2026